Alzheimer'S Disease Clinical Trials in Raleigh, NC

Alzheimer'S Disease Clinical Trials in Raleigh, NC

View the best 10 alzheimer's disease medical studies in Raleigh, North Carolina. Access promising new therapies by applying to a Raleigh-based Alzheimer'S Disease clinical trial.

Top rated alzheimer's disease clinical trials in Raleigh, North Carolina

Here are the top 7 medical studies for alzheimer's disease in Raleigh, North Carolina

Image of Irvine Clinical Research /ID# 250030 in Irvine, United States.

ABBV-552

Verified
Recruiting0 awardsPhase 2
This trial is testing an experimental drug to treat Alzheimer's disease. 240 people aged 50-90 with mild Alzheimer's will take it orally once daily and be monitored.
Image of Duke University Medical Center in Durham, United States.

Network-guided TMS

Neuromodulation

Recruiting1 award6 criteria
This trial will test a new way to use MRI-derived measures of brain connectivity to guide transcranial magnetic stimulation (TMS) to improve memory function in adults with mild cognitive impairment (MCI).
Image of University of Alabama, Birmingham in Birmingham, United States.

Lecanemab +1 More

Monoclonal Antibodies

Recruiting1 awardPhase 3
This trial will test whether lecanemab is better than placebo at improving cognition and reducing brain amyloid accumulation in people with Alzheimer's disease.
Image of Kingfisher Cooperative in Spokane, United States.

AR1001

Verified
Recruiting1 awardPhase 3
This trial is studying a new drug to treat early Alzheimer's. It's a carefully designed, safe study to see if it works.
Image of Valley Clinical Trials, Inc. in Covina, United States.

Donanemab

Monoclonal Antibodies

Verified
Recruiting1 awardPhase 3
This trial will test a new drug, donanemab, for safety and effectiveness in people with early Alzheimer's disease.
Image of Clinical Research Site in Birmingham, United States.

AVP-786

Behavioural Intervention

Verified
Recruiting1 awardPhase 3
This trial will study whether AVP-786, a drug made of deudextromethorphan and quinidine, is better than placebo at treating agitation in people with Alzheimer's Disease.
Image of ARS- Neurology and Neurodiagnostics of Alabama in Hoover, United States.

Donanemab

Monoclonal Antibodies

Recruiting1 awardPhase 3
This trial is studying how safe and effective donanemab is in treating early Alzheimer's disease.

Popular filter options for alzheimer's-disease raleigh trials

Phase 3 Clinical Trials

View 20 phase 3 medical studies.

Clinical Trials With No Placebo

View 20 medical studies that do not have a placebo group.

View More Alzheimer's-disease Raleigh Trials

See another 3 medical studies focused on alzheimer's-disease raleigh.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.